/stocks — the workspaceLOADING
All RCUS SEC filings, by type → · Earnings date & implied move · Search inside filings
Arcus Biosciences, Inc. (RCUS). Piotroski F-Score 0/8. Next earnings projected around 2026-10-27 from RCUS's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind RCUS’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on RCUS plus an auto-SWOT — built from RCUS's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate RCUS using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
No recent 10-K / 10-Q / 8-K filings found.
Has RCUS been issuing shares? Offering history →
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
No lawmaker has disclosed a trade in RCUS under the STOCK Act.
Projected from RCUS's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentRCUS files or announces.
RCUS has sold off after 6 of its last 8 earnings reports.
Each figure is one earnings reaction — how much RCUS moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Earnings reactions have been moderate.
RCUS has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+9.1% and -10.4%).
A more typical earnings reaction has been approximately ±3.0%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-08-05 | -1.6% |
| 2026-05-05 | -0.2% |
| 2026-02-25 | -3.2% |
| 2025-10-28 | +9.1% |
| 2025-08-06 | -2.8% |
| 2025-05-06 | -10.4% |
| 2025-02-25 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -0.2% |
| 2024-11-06 | +7.7% |
No tracked institution reported a position in RCUS in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IJR iShares Core S&P Small-Cap ETF | 0.14% | 2026-06-30 |
| IWM iShares Russell 2000 ETF | 0.09% | 2026-06-30 |
| ITOT iShares Core S&P Total US Stock Market ETF | <0.01% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | <0.01% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
No open-market Form 4 buys or sells reported for RCUS in the last ~6 months.